利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

18 条记录 (耗时 0.039 秒)

    Preventive or therapeutic medicines for diabetes containing fused-heterocyclic compounds or their salts
    5.
    发明授权
    Preventive or therapeutic medicines for diabetes containing fused-heterocyclic compounds or their salts 失效
    含有稠合杂环化合物或其盐的糖尿病的预防或治疗药物

    公开(公告)号：US07067520B2

    公开(公告)日：2006-06-27

    申请号：US10416164

    申请日：2001-11-15

    申请人： Fuminori Kato ,  Hirohiko Kimura ,  Masato Omatsu ,  Kazuhiro Yamamoto ,  Ryuji Miyamoto

    发明人： Fuminori Kato ,  Hirohiko Kimura ,  Masato Omatsu ,  Kazuhiro Yamamoto ,  Ryuji Miyamoto

    IPC分类号： C07D487/04 ,  A61K31/519 ,  A61P3/10 ,  A61P3/06 ,  A61P9/00

    CPC分类号： C07D487/04 ,  A61K31/519

    摘要： The present invention provides a preventive or therapeutic medicine for diabetes containing as an active ingredient a fused-heterocyclic compound of the formula (I′) or its salt: [wherein G is CN, NO2, CO2R4, CHO, SO2NRaRb or CONRaRb; R1 is a halogen atom, a —O—R5 group or a —S—R5 group; R2 is a halogen atom, a —O—R5 group (wherein R5 is as defined above) or an amino group which may be substituted; and each of R8 and R10 which are independent of each other, is a hydrogen atom, a halogen atom or an alkyl group].

    摘要翻译： 本发明提供了含有作为活性成分的式（I'）的稠合杂环化合物或其盐的糖尿病预防或治疗药物：[其中G为CN，NO 2，CO， 2，2，4，4，...，...，...，... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... > a R b ; R 1是卤素原子，-O-R 5基团或-S-R 5+基团; R 2是卤原子，-OR 5基团（其中R 5如上定义）或可被取代的氨基 ; 并且彼此独立的R 8和R 10各自为氢原子，卤原子或烷基]。

    Diaminotrifluoromethylpyridine compounds and phospholipase A.sub.2 inhibitor containing them
    10.
    发明授权
    Diaminotrifluoromethylpyridine compounds and phospholipase A.sub.2 inhibitor containing them 失效
    二氨基三氟甲基吡啶化合物和含有它们的磷脂酶A2抑制剂

    公开(公告)号：US5260320A

    公开(公告)日：1993-11-09

    申请号：US921083

    申请日：1992-07-29

    申请人： Takahiro Haga ,  Hideo Sugi ,  Itaru Shigehara ,  Shinji Odawara ,  Syuichi Yotsuya ,  Hirohiko Kimura ,  Kazuhiro Yamamoto

    发明人： Takahiro Haga ,  Hideo Sugi ,  Itaru Shigehara ,  Shinji Odawara ,  Syuichi Yotsuya ,  Hirohiko Kimura ,  Kazuhiro Yamamoto

    IPC分类号： C07D213/75 ,  C07D213/76 ,  C07D401/12 ,  C07D405/12 ,  C07D409/12 ,  C07D413/12 ,  C07D417/12 ,  C07D453/02 ,  C07D495/04 ,  A61K31/44

    CPC分类号： C07D213/75 ,  C07D213/76 ,  C07D401/12 ,  C07D405/12 ,  C07D409/12 ,  C07D413/10 ,  C07D417/12 ,  C07D453/02 ,  C07D495/04

    摘要： A diaminotrifluoromethylpyridine derivative of the formula (I) or its salt: ##STR1## wherein X is --CW.sup.1 R.sup.1, --COCOR.sup.2, --CW.sup.1 NHCOR.sup.2, --C(.dbd.W.sup.1)W.sup.2 R.sup.3 or --CW.sup.1 N(R.sup.4)R.sup.5, and Y is alkyl, --CW.sup.3 R.sup.6, --COCOR.sup.7, --NHCOR.sup.7, --C(.dbd.W.sup.3)W.sup.4 R.sup.8, --(NH).sub.m SO.sub.2 R.sup.9, --(NH).sub.m SO.sub.2 OR.sup.10 or --(NH).sub.m SO.sub.2 N(R.sup.11)R.sup.12, wherein each of R.sup.1, R.sup.6 and R.sup.9, which are independent from one another, is a chain hydrocarbon group which may be substituted, a monocyclic hydrocarbon group which may be substituted, a polycyclic hydrocarbon group which may be substituted, a monocyclic heterocycle group which may be substituted or a polycyclic heterocycle group which may be substituted, each of R.sup.2 and R.sup.7, which are independent from each other, is alkyl which may be substituted, alkoxy which may be substituted, phenyl which may be substituted or phenoxy which may be substituted, each of R.sup.3, R.sup.8 and R.sup.10, which are independent from one another, is alkyl which may be substituted, alkenyl which may be substituted, alkynyl which may be substituted, cycloalkyl which may be substituted, phenyl which may be substituted or benzyl which may be substituted, each of R.sup.4, R.sup.5, R.sup.11 and R.sup.12, which are independent from one another, is alkyl which may be substituted, each of W.sup.1, W.sup.2, W.sup.3 and W.sup.4, which are independent from one another, is an oxygen atom or a sulfur atom, and m is 0 or 1, provided that a combination wherein one of X and Y is --COCF.sub.2 X.sup.1 wherein X.sup.1 is a hydrogen atom, a halogen atom, alkyl or haloalkyl, and the other is --COCF.sub.2 X.sup.2 wherein X.sup.2 is a hydrogen atom, a halogen atom, alkyl, haloalkyl or alkylcarbonyl, or --COOX.sup.3 wherein X.sup.3 is alkyl which may be substituted or phenyl which may be substituted, is excluded.

    摘要翻译： 式（I）的二氨基三氟甲基吡啶衍生物或其盐：其中X为-CW1R1，-COCOR2，-CW1NHCOR2，-C（= W1）W2R3或-CW1N（R4）R5，Y为烷基 ，-CW 3 R 6，-COCOR 7，-NHCOR 7，-C（= W3）W 4 R 8， - （NH）m SO 2 R 9， - （NH）m SO 2 OR 10或 - （NH）m SO 2 N（R 11）R 12，其中R 1，R 6和R 9各自 彼此独立，可以被取代的链状烃基，可以被取代的单环烃基，可以被取代的多环烃基，可以被取代的单环杂环基或可以被取代的多环杂环基 取代的，R 2和R 7各自独立地为可以被取代的烷基，可以被取代的烷氧基，可以被取代的苯基或可被取代的苯氧基，R 3，R 8和R 10各自为 彼此独立地是可以被取代的烷基，可以被取代的链烯基，可被取代的炔基，其中的环烷基 可被取代的苯基或可被取代的苄基，R 4，R 5，R 11和R 12各自彼此独立地是可以被取代的烷基，各自为W1，W2，W3和W4， 其彼此独立的是氧原子或硫原子，并且m为0或1，条件是其中X和Y之一是-COCF 2 X 1的组合，其中X 1是氢原子，卤素原子，烷基或卤代烷基 另一个是-COCF 2 X 2，其中X 2是氢原子，卤原子，烷基，卤代烷基或烷基羰基，或-COOX 3，其中X 3是可被取代的烷基或可被取代的苯基。